MedPath

Definitive Radiation for High-Risk Spine Metastases

Phase 2
Recruiting
Conditions
Metastatic Tumor
Metastatic Breast Cancer
Spine Metastases
Metastatic Cancer
Metastatic Lung Cancer
Metastatic Tumor to the Spine
Metastatic Tumor of Bone
Metastasis
Registration Number
NCT06165419
Lead Sponsor
Stony Brook University
Brief Summary

This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
26
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT6 months

Assess the efficacy of spine SBRT alone in controlling spine metastases

Secondary Outcome Measures
NameTimeMethod
Progression-free survival6 months
Changes on EuroQol 5 Dimensions 5 Levels (EQ-5D-5L) questionnaire1 months, 3 months, 6 months

The EuroQol 5D-5L questionnaire measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each health dimension is scored from 1 to 5, with 1 indicating a better health state, and 5 the worse state possible. Respondents also indicate their overall health status on visual analogue score, with values ranging from 0 (worst health imaginable) to 100 (best health imaginable)

Changes on Oswestry Low Back Disability Questionnaire1 months, 3 months, 6 months

The Oswestry Disability Index measures disability in patients with low back pain, with scores varying from 0 to 50. Lower scores indicate better outcomes, higher scores indicate a worse outcome.

Changes on Neck Disability index1 months, 3 months, 6 months

The Neck Disability Index measures neck pain and disabilities in patients with neck pain, with scores varying from 0 to 50. Lower scores indicate better outcomes, higher scores indicate a worse outcome.

Reduction in epidural tumor volume3 months

Percent reduction of epidural volume of the treated metastatic lesions

Overall survival6 months

Trial Locations

Locations (1)

Stony Brook University Hospital

🇺🇸

Stony Brook, New York, United States

Stony Brook University Hospital
🇺🇸Stony Brook, New York, United States
Caterina Vacchi-Suzzi, PhD
Contact
631-216-2993
caterina.vacchi-suzzi@stonybrookmedicine.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.